IFNB1 and cancer: IFN-α and IFN-β are involved in the cell cycle-based anti-cancer surveillance and can bind to their receptors on tumor cells to activate a checkpoint to inhibit the cell cycle progression accompanied by senescence and suppressed tumorigenicity [25, 26].